Roslin Cells is the parent company of Roslin Cell Therapies and Roslin Cell Sciences.  Founded in 2006, it has developed two distinct investment and business opportunities in the development and manufacture of cell based therapies and the generation of stem cells to support commercial academic and drug research.

Roslin Cell Therapies is based in Edinburgh, UK, and has a wealth of expertise, capabilities and industry recognition in process translation to GMP, development, optimization, scale up and the GMP manufacture of Cell Therapy and Advanced Therapy Medicinal Products (ATMPs).

Roslin Cell Sciences has facilities in both Edinburgh and Cambridge, UK, the company is capable of creating large numbers of cell lines from various cohorts of donors.  Creating cell lines in this way enables drug research to better understand how drug performance varies between individuals due to their genetic variation

Please contact us at enquires@roslincells.com